Conference Description

SORRY! This conference is full. No more space is available.

September 9, 2006
Doubletree Dallas Market Center
2015 Market Center Blvd.
Dallas, Texas 75207
214-741-7481

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 7.5*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. more fully understand the origins of insulinresistance and type 2 Diabetes, and review studiesof atherosclerosis prevention in patients with type 2Diabetes
2. utilize appropriate first line therapies in thetreatment of diabetes with the goal of targeting thevarious metabolic pathways in the management ofhyperglycemia, thereby preventing development ofcomplications
3. understand the role for insulin in patients with type2 diabetes and develop strategies for initiating andadjusting therapy
4. discuss the epidemiology, diagnostic evaluation,and treatment options of thyroid nodules
5. evaluate and diagnose the anemia of chronickidney disease, understand its impact on quality oflife, and guide treatment decisions based onemerging data
6. identify surrogates of mortality in COPD and betterutilize targeted patient interventions that improvepatient’s outcomes
7. recognize the signs of Pulmonary ArterialHypertension, guide appropriate evaluation anddiscuss the latest therapeutic options
8. utilize evolving data and novel therapies tounderstand and more effectively manage patientswith chronic constipation
9. recognize the importance of achieving therecommended goal blood pressure rather than thesuperiority of a specific antihypertensive overanother in improving patient outcome andunderstanding the importance of combinationtherapy to achieve effective blood pressure control

Agenda:

7:30-8:00 am		Registration, Continental Breakfast and Welcome
8:00-8:10		Welcome Remarks Gregg Sherman, MD
8:10-9:00		Metabolic Syndrome as aMulticomponent Risk Factor forCardiovascular Disease Scott Grundy, MD
9:00-9:50		Treatment Early in the Time Courseof Type 2 Diabetes Patrick J. Boyle, MD
9:50-10:10		Break
10:10-11:00		Thyroid Nodules: Growth in our Knowledge Susan J. Mandel, MD MPH
11:00-11:50		Update on Insulin therapy Pablo F. Mora, MD, FACE, CDE
11:50-12:40		Anemia in Chronic Kidney Disease:Clinical Implications and Treatment Options William McClellan, Jr., MD, MPH
12:40-1:30		Lunch
1:30-2:20		Recent Developments on COPD and its Management Nicholas Gross, MD
2:20-3:10		Pulmonary Hypertension Fernando Torres, MD
3:10-3:30		Break
3:30-4:20		Paving the way to Relief in ChronicConstipation Brooks D. Cash, MD, FACP
4:20-5:10		Hypertension - The Role of theRenin-Angiotensin System, Focus on Target Organ Damage Joshua Furman, MD, FACC
5:10		Conference Wrap Up Gregg Sherman, MD

Faculty:
Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico

Brooks D. Cash, MD, FACP
CDR, MC, USN
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine
National Naval Medical Center

Joshua Furman, MD, FACC
Mount Sinai Medical Center
Miami Beach, Florida

Nicholas Gross, MD
Professor of Medicine at
Stritch-Loyola School of Medicine in Chicago
Member of the Attending Staff at Hines VA Hospital

Scott Grundy, MD
Director, Center for Human Nutrition
The University of Texas
Southwestern Medical Center at Dallas

Susan J. Mandel, MD MPH
Associated Professor of Medicine and Radiology
University of Pennsylvania School of Medicine
Associate Chief for Clinical Affairs
Division of Endocrinology, Diabetes, and Metabolism

William McClellan, Jr., MD, MPH
Professor, Department of Medicine, Division of Renal Medicine
Emory University School of Medicine

Pablo F. Mora, MD FACE CDE
Associate Professor, Department of Internal Medicine,
Division of Endocrinology, Diabetes and Metabolism,
University of Texas Southwestern Medical Center at Dallas, Texas

Fernando Torres, MD
Director Pulmonary Hypertension
St. Paul University Hospital/UTSWMC

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.5 Prescribed credits by the American Academy of Family Physicians.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 7.5 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 9.0 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Abbott Laboratories, Actelion, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.